-
1
-
-
0037030658
-
Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions: a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
-
RAVEL Study Group
-
Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnàr F., Falotico R., and RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions: a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
-
(2002)
N Engl J Med
, vol.346
, pp. 1773-1780
-
-
Morice, M.C.1
Serruys, P.W.2
Sousa, J.E.3
Fajadet, J.4
Ban Hayashi, E.5
Perin, M.6
Colombo, A.7
Schuler, G.8
Barragan, P.9
Guagliumi, G.10
Molnàr, F.11
Falotico, R.12
-
2
-
-
0141765805
-
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
-
SIRIUS Investigators
-
Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
-
(2003)
N Engl J Med
, vol.349
, pp. 1315-1323
-
-
Moses, J.W.1
Leon, M.B.2
Popma, J.J.3
Fitzgerald, P.J.4
Holmes, D.R.5
O'Shaughnessy, C.6
Caputo, R.P.7
Kereiakes, D.J.8
Williams, D.O.9
Teirstein, P.S.10
Jaeger, J.L.11
Kuntz, R.E.12
-
3
-
-
0141863201
-
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
-
E-SIRIUS Investigators
-
Schofer J., Schlüter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G., and E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
-
(2003)
Lancet
, vol.362
, pp. 1093-1099
-
-
Schofer, J.1
Schlüter, M.2
Gershlick, A.H.3
Wijns, W.4
Garcia, E.5
Schampaert, E.6
Breithardt, G.7
-
4
-
-
1542708491
-
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)
-
C-SIRIUS Investigators
-
Schampaert E., Cohen E.A., Schlüter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., Popma J.J., and C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1110-1115
-
-
Schampaert, E.1
Cohen, E.A.2
Schlüter, M.3
Reeves, F.4
Traboulsi, M.5
Title, L.M.6
Kuntz, R.E.7
Popma, J.J.8
-
5
-
-
0037422604
-
TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
-
Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
-
(2003)
Circulation
, vol.107
, pp. 38-42
-
-
Grube, E.1
Silber, S.2
Hauptmann, K.E.3
Mueller, R.4
Buellesfeld, L.5
Gerckens, U.6
Russell, M.E.7
-
6
-
-
0042388295
-
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
-
TAXUS II Study Group
-
Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E., and TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
-
(2003)
Circulation
, vol.108
, pp. 788-794
-
-
Colombo, A.1
Drzewiecki, J.2
Banning, A.3
Grube, E.4
Hauptmann, K.5
Silber, S.6
Dudek, D.7
Fort, S.8
Schiele, F.9
Zmudka, K.10
Guagliumi, G.11
Russell, M.E.12
-
7
-
-
0037417844
-
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation
-
Tanabe K., Serruys P.W., Grube E., Smits P.C., Selbach G., van der Giessen W.J., Staberock M., de Feyter P., Müller R., Regar E., et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107 (2003) 559-564
-
(2003)
Circulation
, vol.107
, pp. 559-564
-
-
Tanabe, K.1
Serruys, P.W.2
Grube, E.3
Smits, P.C.4
Selbach, G.5
van der Giessen, W.J.6
Staberock, M.7
de Feyter, P.8
Müller, R.9
Regar, E.10
-
8
-
-
9144249927
-
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
-
TAXUS-IV Investigators
-
Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
-
(2004)
N Engl J Med
, vol.350
, pp. 221-231
-
-
Stone, G.W.1
Ellis, S.G.2
Cox, D.A.3
Hermiller, J.4
O'Shaughnessy, C.5
Mann, J.T.6
Turco, M.7
Caputo, R.8
Bergin, P.9
Greenberg, J.10
Popma, J.J.11
Russell, M.E.12
-
9
-
-
24644477492
-
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial
-
TAXUS V Investigators
-
Stone G.W., Ellis S.G., Cannon L., Mann J.T., Greenberg J.D., Spriggs D., O'Shaughnessy C.D., DeMaio S., Hall P., Popma J.J., Koglin J., Russell M.E., and TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
-
(2005)
JAMA
, vol.294
, pp. 1215-1223
-
-
Stone, G.W.1
Ellis, S.G.2
Cannon, L.3
Mann, J.T.4
Greenberg, J.D.5
Spriggs, D.6
O'Shaughnessy, C.D.7
DeMaio, S.8
Hall, P.9
Popma, J.J.10
Koglin, J.11
Russell, M.E.12
-
10
-
-
33644775142
-
Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice
-
TAXUS VI Investigators
-
Dawkins K.D., Grube E., Guagliumi G., Banning A.P., Zmudka K., Colombo A., Thuesen L., Hauptmann K., Marco J., Wijns W., et al., TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
-
(2005)
Circulation
, vol.112
, pp. 3306-3313
-
-
Dawkins, K.D.1
Grube, E.2
Guagliumi, G.3
Banning, A.P.4
Zmudka, K.5
Colombo, A.6
Thuesen, L.7
Hauptmann, K.8
Marco, J.9
Wijns, W.10
-
11
-
-
6944237687
-
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
-
McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
-
(2004)
Lancet
, vol.364
, pp. 1519-1521
-
-
McFadden, E.P.1
Stabile, E.2
Regar, E.3
Cheneau, E.4
Ong, A.T.5
Kinnaird, T.6
Suddath, W.O.7
Weissman, N.J.8
Torguson, R.9
Kent, K.M.10
-
12
-
-
33646252464
-
Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings
-
Kotani J., Awata M., Nanto S., Uematsu M., Oshima F., Minamiguchi H., Mintz G.S., and Nagata S. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2108-2111
-
-
Kotani, J.1
Awata, M.2
Nanto, S.3
Uematsu, M.4
Oshima, F.5
Minamiguchi, H.6
Mintz, G.S.7
Nagata, S.8
-
14
-
-
85083133167
-
-
Reuters. New York Times; September 5, 2006 Accessed January 28, 2008
-
Reuters. Cardiologists question the risks in using drug-coated stents. New York Times; September 5, 2006. http://www.nytimes.com/2006/09/05/business/worldbusiness/05stents.html Accessed January 28, 2008
-
Cardiologists question the risks in using drug-coated stents
-
-
-
15
-
-
54549098956
-
-
New York Times; October 12, 2006 Accessed January 28, 2008
-
Feder B.J. Newer stents pose dangers, 2 doctors say. New York Times; October 12, 2006. http://www.nytimes.com/2006/10/12/health/12stent.html Accessed January 28, 2008
-
Newer stents pose dangers, 2 doctors say
-
-
Feder, B.J.1
-
16
-
-
85083120197
-
-
Waltham, Massachusetts: Millennium Research Group, MRG News; February 26, 2007 Accessed January 28, 2008
-
US drug-eluting stent market set to grow to $3 billion by 2011, despite short-term decline [press release]. Waltham, Massachusetts: Millennium Research Group, MRG News; February 26, 2007. http://www.mrg.net/news_newwin.php?news_id=209 Accessed January 28, 2008
-
US drug-eluting stent market set to grow to $3 billion by 2011, despite short-term decline [press release]
-
-
-
17
-
-
33847297900
-
-
US Food and Drug Administration Accessed January 28, 2008
-
US Food and Drug Administration. Update to FDA statement on coronary drug-eluting stents (2007). http://www.fda.gov/cdrh/news/010407.html Accessed January 28, 2008
-
(2007)
Update to FDA statement on coronary drug-eluting stents
-
-
-
18
-
-
33847736642
-
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
-
Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
-
(2007)
N Engl J Med
, vol.356
, pp. 998-1008
-
-
Stone, G.W.1
Moses, J.W.2
Ellis, S.G.3
Schofer, J.4
Dawkins, K.D.5
Morice, M.C.6
Colombo, A.7
Schampaert, E.8
Grube, E.9
Kirtane, A.J.10
-
19
-
-
33847741037
-
A pooled analysis comparing sirolimus-eluting stents with bare-metal stents
-
Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
-
(2007)
N Engl J Med
, vol.356
, pp. 989-997
-
-
Spaulding, C.1
Daemen, J.2
Boersma, E.3
Cutlip, D.E.4
Serruys, P.W.5
-
20
-
-
33847766568
-
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
-
Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabaté M., Suttorp M.J., Baumgart D., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
-
(2007)
N Engl J Med
, vol.356
, pp. 1030-1039
-
-
Kastrati, A.1
Mehilli, J.2
Pache, J.3
Kaiser, C.4
Valgimigli, M.5
Kelbaek, H.6
Menichelli, M.7
Sabaté, M.8
Suttorp, M.J.9
Baumgart, D.10
-
21
-
-
33847762819
-
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden
-
SCAAR Study Group
-
Lagerqvist B., James S.K., Stenestrand U., Lindbäck J., Nilsson T., Wallentin L., and SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
-
(2007)
N Engl J Med
, vol.356
, pp. 1009-1019
-
-
Lagerqvist, B.1
James, S.K.2
Stenestrand, U.3
Lindbäck, J.4
Nilsson, T.5
Wallentin, L.6
-
22
-
-
85083138401
-
-
SCAAR Study Group. Presented at the European Society of Cardiology Annual Congress; September 1-5 Vienna, Austria. Clinical trial update I; 1021
-
James S., Carlsson J., Lindbäck J., Nilsson T., Stenestrand U., Wallentin L., Lagerqvist B., and SCAAR Study Group. Long term mortality after drug eluting stents in Sweden: an additional year of follow-up. Presented at the European Society of Cardiology Annual Congress; September 1-5 (2007) Vienna, Austria. Clinical trial update I; 1021
-
(2007)
Long term mortality after drug eluting stents in Sweden: an additional year of follow-up
-
-
James, S.1
Carlsson, J.2
Lindbäck, J.3
Nilsson, T.4
Stenestrand, U.5
Wallentin, L.6
Lagerqvist, B.7
-
23
-
-
34948904387
-
Effectiveness and safety of drug-eluting stents in Ontario
-
Tu J.V., Bowen J., Chiu M., Ko D.T., Austin P.C., He Y., Hopkins R., Tarride J.E., Blackhouse G., Lazzam C., Cohen E.A., and Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
-
(2007)
N Engl J Med
, vol.357
, pp. 1393-1402
-
-
Tu, J.V.1
Bowen, J.2
Chiu, M.3
Ko, D.T.4
Austin, P.C.5
He, Y.6
Hopkins, R.7
Tarride, J.E.8
Blackhouse, G.9
Lazzam, C.10
Cohen, E.A.11
Goeree, R.12
-
24
-
-
33847167065
-
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
-
Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Jüni P., Sianos G., Hellige G., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
-
(2007)
Lancet
, vol.369
, pp. 667-678
-
-
Daemen, J.1
Wenaweser, P.2
Tsuchida, K.3
Abrecht, L.4
Vaina, S.5
Morger, C.6
Kukreja, N.7
Jüni, P.8
Sianos, G.9
Hellige, G.10
-
25
-
-
34548542073
-
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
-
Stettler C., Wandel S., Allemann S., Kastrati A., Morice M., Schömig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
-
(2007)
Lancet
, vol.370
, pp. 937-948
-
-
Stettler, C.1
Wandel, S.2
Allemann, S.3
Kastrati, A.4
Morice, M.5
Schömig, A.6
Pfisterer, M.E.7
Stone, G.W.8
Leon, M.B.9
de Lezo, J.S.10
-
26
-
-
34249877707
-
Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare-metal stent implantation
-
Stone G.W., Ellis S.G., Colombo A., Dawkins K.D., Grube E., Cutlip D.E., Friedman M., Baim D.S., and Koglin J. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare-metal stent implantation. Circulation 115 (2007) 2842-2847
-
(2007)
Circulation
, vol.115
, pp. 2842-2847
-
-
Stone, G.W.1
Ellis, S.G.2
Colombo, A.3
Dawkins, K.D.4
Grube, E.5
Cutlip, D.E.6
Friedman, M.7
Baim, D.S.8
Koglin, J.9
-
27
-
-
38049169354
-
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention
-
2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, writing on behalf of the 2005 Writing Committee
-
King III S.B., Smith Jr. S.C., Hirshfeld Jr. J.W., Jacobs A.K., Morrison D.A., Williams D.O., 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, and writing on behalf of the 2005 Writing Committee. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circulation 117 (2008) 261-295
-
(2008)
Circulation
, vol.117
, pp. 261-295
-
-
King III, S.B.1
Smith Jr., S.C.2
Hirshfeld Jr., J.W.3
Jacobs, A.K.4
Morrison, D.A.5
Williams, D.O.6
|